SIRP-γ Activators
SIRP-γ (Signal Regulatory Protein-γ) activators represent a class of compounds that play a crucial role in regulating the immune system by modulating the activity of SIRP-γ, a transmembrane protein primarily found on the surface of immune cells such as macrophages, dendritic cells, and neutrophils. SIRP-γ is a member of the SIRP family of proteins, which are involved in signal transduction and immune responses. SIRP-γ, in particular, is known for its role in mediating cell-to-cell communication in the immune system. It is predominantly expressed in myeloid cells, and its activation can have a significant impact on the immune response.
SIRP-γ activators are designed to interact with the extracellular domain of the SIRP-γ receptor, which contains immunoglobulin-like domains. When activated, these compounds can trigger a cascade of signaling events within immune cells, ultimately influencing their behavior and function. By binding to SIRP-γ, activators can either enhance or inhibit the receptor's signaling, depending on their specific mode of action. This modulation can result in a variety of effects, such as promoting phagocytosis of pathogens, altering cytokine production, or influencing immune cell migration. The development and study of SIRP-γ activators hold promise for a deeper understanding of immune regulation and could potentially lead to novel approaches for manipulating the immune response.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
As a tyrosine kinase inhibitor, Imatinib could indirectly boost SIRP-γ activation by interfering with phosphorylation events of proteins involved in SIRP-γ signaling pathways. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A PI3K inhibitor, Wortmannin may indirectly promote SIRP-γ activation by disrupting the PI3K pathway, which can interact with SIRP-γ signaling. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
By inhibiting mTOR, Rapamycin may indirectly invigorate SIRP-γ activation, as mTOR is connected to immune cell signaling pathways where SIRP-γ plays a role. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
This Src kinase inhibitor could indirectly stimulate SIRP-γ activation by interfering with signaling events mediated by Src kinases, which may be linked to SIRP-γ. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Inhibiting Protein Kinase C with Staurosporine may indirectly invigorate SIRP-γ activation by interfering with signaling events related to immune cell regulation. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Inhibiting calcineurin with Cyclosporin A may indirectly enhance SIRP-γ activation by disrupting the calcineurin-dependent signaling pathway, which can interact with immune regulation mechanisms involving SIRP-γ. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $71.00 $202.00 | 18 | |
SB216763, a GSK-3 inhibitor, may indirectly boost SIRP-γ activation by affecting signaling events related to GSK-3, which can be involved in immune cell signaling and SIRP-γ regulation. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
This NF-κB inhibitor, BAY 11-7082, may indirectly promote SIRP-γ activation by interfering with the transcription of genes connected to SIRP-γ signaling and immune responses. | ||||||